trending Market Intelligence /marketintelligence/en/news-insights/trending/wzDNaRbHle3P-at5vrP_KA2 content esgSubNav
In This List

Bellicum appoints president, CEO

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Bellicum appoints president, CEO

Rick Fair was appointed Bellicum Pharmaceuticals Inc.'s president, CEO and member of the company's board.

Fair succeeds Tom Farrell who would serve as an adviser to the company during the transition. Fair was senior vice president and head of oncology global product strategy at Genentech, a Roche Holding Ltd. subsidiary.